Scientific Clinical Wide Aspect Ratio 1200 384

Scientific & Clinical Advisors

Trusted advisors with deep expertise

We are able to turn to our advisors to discuss new ideas and approaches to our science and clinical advancements.

  • Steven Devine 1x1

    Steven Devine, MD

    Clinical Advisor

    Steven Devine, MD is Associate Scientific Director/Senior Vice President of Research at the Center for International Blood and Marrow Transplant Research (CIBMTR), a research collaboration between the National Marrow Donor Program, also known as Be The Match, and the Medical College of Wisconsin. ...

  • Hans Peter Kim 1x1

    Hans-Peter Kiem, MD, PhD

    Scientific & Clinical Advisor

    The research of Hans-Peter Kiem, MD, PhD has focused on stem cell and transplantation biology, cell and gene therapy, and the development and use of novel gene-editing technologies. The overall goal has been the development of improved treatment approaches for patients with genetic and ...

  • Rob Soiffer 1x1

    Rob Soiffer

    Clinical Advisor

    Rob Soiffer, MD is currently Chief of the Division of Hematologic Malignancies and Co-Director of the Adult Stem Cell Transplantation Program at the Dana-Farber Cancer Institute. He joined Dana-Farber in 1988 after completing a medical oncology fellowship also at Dana-Farber. Rob is Chairman of the ...

Clinical Advisor

Steven Devine, MD

Steven Devine, MD is Associate Scientific Director/Senior Vice President of Research at the Center for International Blood and Marrow Transplant Research (CIBMTR), a research collaboration between the National Marrow Donor Program, also known as Be The Match, and the Medical College of Wisconsin. Steven is a board-certified oncologist and was the Director of the Blood and Marrow Transplant Program at Ohio State University Hospital in Columbus. Prior to that, he held positions at Washington University in St. Louis, the University of Illinois in Chicago, and Emory University in Atlanta. He also served on the graft-versus-host disease advisory boards of Bristol-Myers Squibb and Incyte Pharmaceuticals, the Kiadis advisory board and the Genzyme advisory board.

Steven is immediate Past-Chair of the National Heart Lung and Blood Institute/NCI-sponsored Blood and Marrow Transplant Clinical Trials Network. He has also served as a member of the Board of Directors of the National Cancer Institute (NCI) Alliance for Clinical Trials and the American Society of Blood and Marrow Transplantation.

Steven received his MD from the University of Massachusetts and completed his internship and residency at Michael Reese Hospital in Chicago. He then went on to complete a clinical fellowship of hematology and oncology at the University of Chicago and completed his fellowship in bone marrow transplant at Emory University.

Steven Devine 1x1

Scientific & Clinical Advisor

Hans-Peter Kiem, MD, PhD

The research of Hans-Peter Kiem, MD, PhD has focused on stem cell and transplantation biology, cell and gene therapy, and the development and use of novel gene-editing technologies. The overall goal has been the development of improved treatment approaches for patients with genetic and infectious diseases and cancer, in particular, hematologic malignancies. He is a clinically active hematologist/oncologist seeing patients on the marrow transplant, immunotherapy, and MDS/AML service. Hans-Peter has extensive experience training students and postdoctoral fellows and has mentored more than 50 trainees in his lab over the past 20 years. Many of his trainees now hold tenured faculty positions in the U.S. and Germany. Hans-Peter has been the Sponsor of four clinical gene therapy studies (HIV, glioblastoma, and Fanconi anemia) and he is the PI or Co-PI of many R01 or Program Project grants. Hans-Peter has also served on the NIH Recombinant DNA Advisory Committee (RAC) for five years, the last year as Chair, and served as the Chair of the Stem Cell Committees for both the American Society for Gene and Cell Therapy (ASGCT) and the American Society of Hematology.

Hans-Peter received his MD and PhD degrees from the University of Ulm in Germany and then joined Dr. Karl Blume’s research group at Stanford University as a research fellow, working with Drs. Sklar and Cleary to study molecular abnormalities and minimal residual in patients with lymphoma (Oncogene 1990; Blood 1991) and with Drs. Weissman and Negrin on the use of a novel immunodeficient mouse model for lymphoma (J. Exp. Med. 1991). After a two-year fellowship at Stanford, Hans-Peter went on to complete his residency in Internal Medicine and his Physician/Scientist training at Vanderbilt University. He joined the Fred Hutchinson Cancer Research Center in 1992, where he completed his clinical fellowship in Oncology.

Hans Peter Kim 1x1

Clinical Advisor

Rob Soiffer

Rob Soiffer, MD is currently Chief of the Division of Hematologic Malignancies and Co-Director of the Adult Stem Cell Transplantation Program at the Dana-Farber Cancer Institute. He joined Dana-Farber in 1988 after completing a medical oncology fellowship also at Dana-Farber. Rob is Chairman of the Center for International Blood and Marrow Transplant Research advisory committee and has served as Vice President (2006), President (2007), and immediate Past President (2008) of the American Society of Blood and Marrow Transplantation. Rob graduated from New York University School of Medicine in 1983 and trained in internal medicine at Brigham and Women’s Hospital, where he also was chief medical resident.

Rob Soiffer 1x1
The Science

The science behind our approach

Vor Bio is working to potentially protect HSCs from targeted therapies post-transplant.

Our founding story

Vor Bio was founded on an elegant and profound idea from Dr. Siddhartha Mukherjee—protect the healthy cells, expose the cancer.